{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:24:51Z","timestamp":1791404691606,"version":"4.3.3"},"reference-count":151,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82222033"],"award-info":[{"award-number":["82222033"]}]},{"name":"National Natural Science Foundation of China","award":["82172003"],"award-info":[{"award-number":["82172003"]}]},{"name":"National Natural Science Foundation of China","award":["82402458"],"award-info":[{"award-number":["82402458"]}]},{"name":"National Natural Science Foundation of China","award":["2024C035"],"award-info":[{"award-number":["2024C035"]}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["82222033"],"award-info":[{"award-number":["82222033"]}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["82172003"],"award-info":[{"award-number":["82172003"]}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["82402458"],"award-info":[{"award-number":["82402458"]}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["2024C035"],"award-info":[{"award-number":["2024C035"]}]},{"name":"Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University","award":["82222033"],"award-info":[{"award-number":["82222033"]}]},{"name":"Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University","award":["82172003"],"award-info":[{"award-number":["82172003"]}]},{"name":"Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University","award":["82402458"],"award-info":[{"award-number":["82402458"]}]},{"name":"Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University","award":["2024C035"],"award-info":[{"award-number":["2024C035"]}]},{"name":"Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)","award":["82222033"],"award-info":[{"award-number":["82222033"]}]},{"name":"Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)","award":["82172003"],"award-info":[{"award-number":["82172003"]}]},{"name":"Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)","award":["82402458"],"award-info":[{"award-number":["82402458"]}]},{"name":"Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)","award":["2024C035"],"award-info":[{"award-number":["2024C035"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra and the accumulation of \u03b1-synuclein in the brain. Ferroptosis, a recently identified form of regulated cell death, is critical in PD pathogenesis due to its association with iron deposition, overproduction of reactive oxygen species, iron-dependent lipid peroxidation and impaired lipid peroxidation clearance. This cell death mechanism is closely linked to several pathogenic processes in PD, including \u03b1-synuclein aggregation, oxidative stress, mitochondrial dysfunction, microglia-induced neuroinflammation, and neuromelanin accumulation. Given the significant role of ferroptosis in these mechanisms, there is increasing interest in targeting ferroptosis for PD treatment. Several drugs have shown potential in alleviating PD symptoms by inhibiting ferroptosis. This review aims to consolidate current knowledge on ferroptosis in PD and assess the therapeutic potential of anti-ferroptosis drugs, highlighting promising directions for future research and clinical applications.<\/jats:p>","DOI":"10.3390\/ijms252313042","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T06:38:25Z","timestamp":1733294305000},"page":"13042","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Targeting Ferroptosis in Parkinson\u2019s Disease: Mechanisms and Emerging Therapeutic Strategies"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8014-5093","authenticated-orcid":false,"given":"Minghao","family":"Zhou","sequence":"first","affiliation":[{"name":"Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyang","family":"Xu","sequence":"additional","affiliation":[{"name":"Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-1083","authenticated-orcid":false,"given":"Jianxian","family":"Ge","sequence":"additional","affiliation":[{"name":"Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingnian","family":"Luo","sequence":"additional","affiliation":[{"name":"Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_2","first-page":"132","article-title":"Mr. Parkinson\u2019s Letter on the Committee of Apothecaries","volume":"29","author":"Parkinson","year":"1813","journal-title":"Med. Phys. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/00207454.2018.1538993","article-title":"Pharmacogenetics and levodopa induced motor complications","volume":"129","author":"Kalinderi","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.euroneuro.2023.02.017","article-title":"Predicting impulse control disorder in Parkinson\u2019s Disease: Is there a formula?","volume":"72","author":"Valldeoriola","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41419-021-04490-1","article-title":"Double-edge sword roles of iron in driving energy production versus instigating ferroptosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","article-title":"Ferroptosis: A cell death connecting oxidative stress, inflammation and cardiovascular diseases","volume":"7","author":"Yu","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mahoney-S\u00e1nchez, L., Bouchaoui, H., Ayton, S., Devos, D., Duce, J.A., and Devedjian, J.C. (2021). Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s Disease. Progress. Neurobiol., 196.","DOI":"10.1016\/j.pneurobio.2020.101890"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nagatsu, T., and Sawada, M. (2007). Biochemistry of postmortem brains in Parkinson\u2019s disease: Historical overview and future prospects. Neuropsychiatric Disorders An Integrative Approach. Journal of Neural Transmission, Springer.","DOI":"10.1007\/978-3-211-73574-9_14"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s12035-016-9879-1","article-title":"Brain Iron Metabolism Dysfunction in Parkinson\u2019s Disease","volume":"54","author":"Jiang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"ref_13","first-page":"217","article-title":"Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases","volume":"5","author":"Melki","year":"2015","journal-title":"J. Park. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12291-009-0017-y","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"24","author":"Nikam","year":"2009","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_17","first-page":"1","article-title":"Human neuromelanin: An endogenous microglial activator for dopaminergic neuron death","volume":"5","author":"Zhang","year":"2013","journal-title":"Front. Biosci. (Elite Ed)"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.14810","article-title":"The physiological role of \u03b1-synuclein and its relationship to Parkinson\u2019s Disease","volume":"150","author":"Sulzer","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16116","DOI":"10.1074\/jbc.M107866200","article-title":"Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein","volume":"277","author":"Golts","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhao, Q., Tao, Y., Zhao, K., Ma, Y., Xu, Q., Liu, C., Zhang, S., and Li, D. (2023). Structural Insights of Fe(3+) Induced \u03b1-synuclein Fibrillation in Parkinson\u2019s Disease. J. Mol. Biol., 435.","DOI":"10.1016\/j.jmb.2022.167680"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13024-017-0218-4","article-title":"Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases","volume":"12","author":"Zhou","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","article-title":"Accumulation of phosphorylated alpha-synuclein in aging human brain","volume":"62","author":"Saito","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e179633","DOI":"10.1172\/JCI179633","article-title":"Deficiency of parkin causes neurodegeneration and accumulation of pathological \u03b1-synuclein in monkey models","volume":"134","author":"Han","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuint.2019.02.016","article-title":"Iron-induced oxidative stress contributes to \u03b1-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2","volume":"125","author":"Wang","year":"2019","journal-title":"Neurochem. Int."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Davies, P., Moualla, D., and Brown, D.R. (2011). Alpha-synuclein is a cellular ferrireductase. PLoS ONE, 6.","DOI":"10.1371\/annotation\/900a5247-7d03-4686-a544-5f7f64c0aac5"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","article-title":"Alpha synuclein aggregation drives ferroptosis: An interplay of iron, calcium and lipid peroxidation","volume":"27","author":"Angelova","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108373","DOI":"10.1016\/j.pharmthera.2023.108373","article-title":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","volume":"244","author":"Costa","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"111231","DOI":"10.1016\/j.celrep.2022.111231","article-title":"Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition","volume":"40","author":"Bouchaoui","year":"2022","journal-title":"Cell Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3164\/jcbn.18-25","article-title":"Modification of \u03b1-synuclein by lipid peroxidation products derived from polyunsaturated fatty acids promotes toxic oligomerization: Its relevance to Parkinson disease","volume":"62","author":"Hisaka","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10715762.2024.2336563","article-title":"Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic death induced by erastin in SH-SY5Y cells","volume":"58","author":"Ganguly","year":"2024","journal-title":"Free Radic. Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wu, L., Liu, M., Liang, J., Li, N., Yang, D., Cai, J., Zhang, Y., He, Y., Chen, Z., and Ma, T. (2021). Ferroptosis as a New Mechanism in Parkinson\u2019s Disease Therapy Using Traditional Chinese Medicine. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.659584"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-020-15065-7","article-title":"Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson\u2019s disease","volume":"11","author":"Vallerga","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.3390\/molecules20058742","article-title":"Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1)","volume":"20","author":"Aoyama","year":"2015","journal-title":"Molecules"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Battaglia, A.M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F., and Biamonte, F. (2020). Ferroptosis and Cancer: Mitochondria Meet the \u201cIron Maiden\u201d Cell Death. Cells, 9.","DOI":"10.3390\/cells9061505"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41467-020-15109-y","article-title":"DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase","volume":"11","author":"Cao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1016\/j.csbj.2022.09.018","article-title":"Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson\u2019s disease","volume":"20","author":"Jian","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1111\/ene.15509","article-title":"The mutation spectrum of Parkinson-disease-related genes in early-onset Parkinson\u2019s disease in ethnic Chinese","volume":"29","author":"Chen","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Schneider","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wu, H., Wang, F., Ta, N., Zhang, T., and Gao, W. (2021). The Multifaceted Regulation of Mitochondria in Ferroptosis. Life, 11.","DOI":"10.3390\/life11030222"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/aww022","article-title":"Iron and dopamine: A toxic couple","volume":"139","author":"Hare","year":"2016","journal-title":"Brain"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"24437","DOI":"10.1074\/jbc.C100141200","article-title":"A human mitochondrial ferritin encoded by an intronless gene","volume":"276","author":"Levi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","article-title":"Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC","volume":"94","author":"Gouel","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11064-020-03186-w","article-title":"Idebenone Ameliorates Rotenone-Induced Parkinson\u2019s Disease in Rats Through Decreasing Lipid Peroxidation","volume":"46","author":"Yavuz","year":"2021","journal-title":"Neurochem. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature05859","article-title":"RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00018-022-04389-w","article-title":"Restricting \u03b1-synuclein transport into mitochondria by inhibition of \u03b1-synuclein-VDAC complexation as a potential therapeutic target for Parkinson\u2019s disease treatment","volume":"79","author":"Rajendran","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","article-title":"Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes","volume":"112","author":"Scheiblich","year":"2024","journal-title":"Neuron"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pneurobio.2016.04.006","article-title":"Microglial phenotypes in Parkinson\u2019s disease and animal models of the disease","volume":"155","author":"Joers","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","article-title":"Microglia-Mediated Inflammation and Neurodegenerative Disease","volume":"53","author":"Xu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jnc.12244","article-title":"Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells","volume":"126","author":"Urrutia","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41593-022-01221-3","article-title":"Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration","volume":"26","author":"Ryan","year":"2023","journal-title":"Nat. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2008.05541.x","article-title":"Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson\u2019s disease","volume":"106","author":"Zecca","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00702-011-0753-z","article-title":"Neuromelanin enhances the toxicity of \u03b1-synuclein in SK-N-SH cells","volume":"119","author":"Li","year":"2012","journal-title":"J. Neural Transm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1073\/pnas.0913192107","article-title":"Binding and uptake of H-ferritin are mediated by human transferrin receptor-1","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","article-title":"FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson\u2019s Disease","volume":"17","author":"Tian","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1021\/acs.jmedchem.0c01480","article-title":"Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities","volume":"63","author":"Jiang","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.020","article-title":"DMT1 and iron transport","volume":"133","author":"Yanatori","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4103\/1673-5374.380889","article-title":"Iron regulatory protein 1: The deadly switch of ferroptosis","volume":"19","author":"Urrutia","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"110991","DOI":"10.1016\/j.brainresbull.2024.110991","article-title":"The molecular mechanism of ferroptosis and its relationship with Parkinson\u2019s disease","volume":"213","author":"Su","year":"2024","journal-title":"Brain Res. Bull."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11064-021-03262-9","article-title":"Benefits of Iron Chelators in the Treatment of Parkinson\u2019s Disease","volume":"46","author":"Zeng","year":"2021","journal-title":"Neurochem. Res."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Chen, X., Yu, C., Kang, R., and Tang, D. (2020). Iron Metabolism in Ferroptosis. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.590226"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Martin-Bastida, A., Ward, R.J., Newbould, R., Piccini, P., Sharp, D., Kabba, C., Patel, M.C., Spino, M., Connelly, J., and Tricta, F. (2017). Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-01402-2"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/sigtrans.2016.15","article-title":"Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson\u2019s substantia nigra","volume":"1","author":"Ayton","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-017-0456-2","article-title":"The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson\u2019s disease","volume":"5","author":"Finkelstein","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1471-4159.2005.03340.x","article-title":"Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: In vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition","volume":"95","author":"Zheng","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","article-title":"Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats","volume":"46","author":"Shachar","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","article-title":"Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators","volume":"21","author":"Zhu","year":"2007","journal-title":"FASEB J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bmc.2004.10.037","article-title":"Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer\u2019s, Parkinson\u2019s, and other neurodegenerative diseases","volume":"13","author":"Zheng","year":"2005","journal-title":"Bioorganic Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(79)90928-0","article-title":"Clioquinol and S.M.O.N.: Reanalysis of original data","volume":"1","author":"Asao","year":"1979","journal-title":"Lancet"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9515","DOI":"10.18632\/aging.103225","article-title":"Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson\u2019s disease through AKT\/mTOR pathway","volume":"12","author":"Shi","year":"2020","journal-title":"Aging"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12264-012-1238-2","article-title":"Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson\u2019s disease","volume":"28","author":"Du","year":"2012","journal-title":"Neurosci. Bull."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4236\/cellbio.2013.22005","article-title":"Protective Effects of Flavonoid Baicalein against Menadione-Induced Damage in SK-N-MC Cells","volume":"2","author":"Yazdanparast","year":"2013","journal-title":"CellBio"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jnr.23307","article-title":"Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson\u2019s disease model by downregulating the activations of nuclear factor-\u03baB, ERK, and JNK","volume":"92","author":"Lee","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2017.06.031","article-title":"Baicalein blocks \u03b1-synuclein secretion from SN4741 cells and facilitates \u03b1-synuclein polymerization to big complex","volume":"655","author":"Li","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"102431","DOI":"10.1016\/j.isci.2021.102431","article-title":"Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis","volume":"24","author":"Song","year":"2021","journal-title":"iScience"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/00207454.2021.1885403","article-title":"A novel treatment strategy to prevent Parkinson\u2019s disease: Focus on iron regulatory protein 1 (IRP1)","volume":"133","author":"Berry","year":"2023","journal-title":"Int. J. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3892\/ijmm.2021.4894","article-title":"miR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson\u2019s disease","volume":"47","author":"Li","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neures.2013.09.003","article-title":"Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP\u207a as Parkinson\u2019s disease cellular model","volume":"77","author":"Asci","year":"2013","journal-title":"Neurosci. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12012-023-09804-7","article-title":"Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways","volume":"23","author":"Iqbal","year":"2023","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_84","first-page":"e50960","article-title":"Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson\u2019s disease","volume":"83","author":"Chou","year":"2014","journal-title":"J. Vis. Exp."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s13238-021-00823-0","article-title":"Cytochrome P450 reductase (POR) as a ferroptosis fuel","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuint.2017.03.014","article-title":"The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial","volume":"108","author":"Taghizadeh","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/bph.14881","article-title":"Cu(II) (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease","volume":"177","author":"Southon","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"19043","DOI":"10.1021\/jacs.1c08254","article-title":"Radical-Trapping Antioxidant Activity of Copper and Nickel Bis(Thiosemicarbazone) Complexes Underlies Their Potency as Inhibitors of Ferroptotic Cell Death","volume":"143","author":"Zilka","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/med.21939","article-title":"Novel druggable mechanism of Parkinson\u2019s disease: Potential therapeutics and underlying pathogenesis based on ferroptosis","volume":"43","author":"Jiang","year":"2023","journal-title":"Med. Res. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1021\/acs.jmedchem.8b01299","article-title":"Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy","volume":"61","author":"Devisscher","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ji, H.L., Zhang, Y.F., Zhang, N.Y., Wang, K.M., Meng, N., Zhang, J., and Jiang, C.S. (2024). Design, synthesis, and evaluation of formylpiperazine analogs of Ferrostatin-1 as novel improved ferroptosis inhibitors. Bioorganic Med. Chem., 105.","DOI":"10.1016\/j.bmc.2024.117716"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acs.biomac.3c01106","article-title":"Schiff-Base Cross-Linked Poly(2-oxazoline) Micelle Drug Conjugates Possess Antiferroptosis Activity in Numerous In Vitro Cell Models","volume":"25","author":"Morrow","year":"2024","journal-title":"Biomacromolecules"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/acs.nanolett.2c05056","article-title":"Intranasal Pathway for Nanoparticles to Enter the Central Nervous System","volume":"23","author":"Kou","year":"2023","journal-title":"Nano Lett."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4103\/NRR.NRR-D-23-02051","article-title":"Exosomes: The next-generation therapeutic platform for ischemic stroke","volume":"20","author":"Yin","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"eadk1200","DOI":"10.1126\/sciadv.adk1200","article-title":"Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases","volume":"10","author":"Huang","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Yue, M., Wei, J., Chen, W., Hong, D., Chen, T., and Fang, X. (2022). Neurotrophic Role of the Next-Generation Probiotic Strain L. lactis MG1363-pMG36e-GLP-1 on Parkinson\u2019s Disease via Inhibiting Ferroptosis. Nutrients, 14.","DOI":"10.3390\/nu14224886"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1021\/acschembio.2c00317","article-title":"LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis","volume":"17","author":"Reed","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"106779","DOI":"10.1016\/j.phrs.2023.106779","article-title":"ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis","volume":"193","author":"Li","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"106587","DOI":"10.1016\/j.prostaglandins.2021.106587","article-title":"Licofelone, a potent COX\/5-LOX inhibitor and a novel option for treatment of neurological disorders","volume":"157","author":"Razavi","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jnc.13024","article-title":"Lipid peroxidation is essential for \u03b1-synuclein-induced cell death","volume":"133","author":"Angelova","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41419-020-2312-8","article-title":"Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling","volume":"11","author":"Ke","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41467-021-23902-6","article-title":"iPLA2\u03b2-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"113863","DOI":"10.1016\/j.expneurol.2021.113863","article-title":"PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models","volume":"346","author":"Yeh","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"107114","DOI":"10.1016\/j.phrs.2024.107114","article-title":"Unveiling the role of iPLA(2)\u03b2 in neurodegeneration: From molecular mechanisms to advanced therapies","volume":"202","author":"Liu","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_111","first-page":"289","article-title":"Phase IIb Study of Intranasal Glutathione in Parkinson\u2019s Disease","volume":"7","author":"Mischley","year":"2017","journal-title":"J. Park. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0278-5846(96)00103-0","article-title":"Reduced intravenous glutathione in the treatment of early Parkinson\u2019s disease","volume":"20","author":"Sechi","year":"1996","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jcph.1008","article-title":"Repeated-Dose Oral N-Acetylcysteine in Parkinson\u2019s Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress","volume":"58","author":"Coles","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2012.03.023","article-title":"Coenzyme Q10 deficiency in patients with Parkinson\u2019s disease","volume":"318","author":"Mischley","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1007\/s12035-021-02320-1","article-title":"Thioredoxin-1 Rescues MPP(+)\/MPTP-Induced Ferroptosis by Increasing Glutathione Peroxidase 4","volume":"58","author":"Bai","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"414","DOI":"10.26599\/FSHW.2022.9250035","article-title":"Total flavonoids of Astragalus membranaceus protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice by inhibiting ferroptosis through SLC7A11\/GPX-4 signaling pathway","volume":"13","author":"Gao","year":"2024","journal-title":"Food Sci. Hum. Wellness"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clnesp.2022.01.023","article-title":"A feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue and fatigability in people with Parkinson\u2019s (pwP)","volume":"48","author":"Coe","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40261-016-0418-7","article-title":"Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers","volume":"36","author":"Pang","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Adinolfi, S., Patinen, T., Jawahar Deen, A., Pitk\u00e4nen, S., H\u00e4rk\u00f6nen, J., Kansanen, E., K\u00fcblbeck, J., and Levonen, A.L. (2023). The KEAP1-NRF2 pathway: Targets for therapy and role in cancer. Redox Biol., 63.","DOI":"10.1016\/j.redox.2023.102726"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10715762.2023.2243032","article-title":"Molecular targets for anti-oxidative protection of a\u00e7a\u00ed berry against diabetes myocardial ischemia\/reperfusion injury","volume":"57","author":"Impellizzeri","year":"2023","journal-title":"Free Radic. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"175133","DOI":"10.1016\/j.ejphar.2022.175133","article-title":"Therapeutic Insights on Ferroptosis in Parkinson\u2019s disease","volume":"930","author":"Thapa","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.abb.2006.08.005","article-title":"Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion","volume":"454","author":"Osburn","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1089\/ars.2017.7176","article-title":"The Roles of NRF2 in Modulating Cellular Iron Homeostasis","volume":"29","author":"Kerins","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"114541","DOI":"10.1016\/j.expneurol.2023.114541","article-title":"Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2\/SLC7A11\/GPX4 pathway","volume":"369","author":"Liu","year":"2023","journal-title":"Exp. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbagen.2014.11.021","article-title":"Nrf2 regulates ROS production by mitochondria and NADPH oxidase","volume":"1850","author":"Kovac","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2017.02.005","article-title":"Protective effect of Nrf2-ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson\u2019s disease model","volume":"798","author":"Masaki","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cbin.11505","article-title":"\u03b1-Lipoic acid alleviates ferroptosis in the MPP+-induced PC12 cells via activating the PI3K\/Akt\/Nrf2 pathway","volume":"45","author":"Liu","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.55782\/ane-2021-037","article-title":"Lipoic acid alleviates LPS-evoked PC12 cell damage by targeting p53 and inactivating the NF-\u03baB pathway","volume":"81","author":"Mao","year":"2021","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"101817","DOI":"10.1016\/j.arr.2022.101817","article-title":"PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases","volume":"84","author":"Li","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2024.07.018","article-title":"Acteoside alleviates lipid peroxidation by enhancing Nrf2-mediated mitophagy to inhibit ferroptosis for neuroprotection in Parkinson\u2019s disease","volume":"223","author":"Han","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/s41418-021-00767-2","article-title":"The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson\u2019s disease","volume":"28","author":"Zhao","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_134","first-page":"109","article-title":"A rat model of ataxia-telangiectasia: Evidence for a neurodegenerative phenotype","volume":"26","author":"Quek","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/glia.23592","article-title":"Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression","volume":"67","author":"Nazmi","year":"2019","journal-title":"Glia"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7883\/yoken.52.89","article-title":"Viral etiology for Parkinson\u2019s disease--a possible role of influenza A virus infection","volume":"52","author":"Takahashi","year":"1999","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"10680","DOI":"10.1038\/ncomms10680","article-title":"Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses","volume":"7","author":"Holm","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","article-title":"Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism","volume":"104","author":"Cleren","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","article-title":"Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease","volume":"64","author":"Storch","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson\u2019s disease","volume":"341","author":"Gholipour","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Erb, M., Hoffmann-Enger, B., Deppe, H., Soeberdt, M., Haefeli, R.H., Rummey, C., Feurer, A., and Gueven, N. (2012). Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036153"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Montenegro, L., Turnaturi, R., Parenti, C., and Pasquinucci, L. (2018). Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy. Nanomaterials, 8.","DOI":"10.3390\/nano8020087"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-022-00826-8","article-title":"Idebenone improves motor dysfunction, learning and memory by regulating mitophagy in MPTP-treated mice","volume":"8","author":"Yan","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"114151","DOI":"10.1016\/j.ejmech.2022.114151","article-title":"Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents","volume":"231","author":"Fang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e1976","DOI":"10.1212\/WNL.0000000000200182","article-title":"Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults","volume":"98","author":"Oveisgharan","year":"2022","journal-title":"Neurology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/mds.29884","article-title":"Targeting Glucagon-Like Peptide 1 Signaling: A Potential Disease Modifying Therapy for Parkinson\u2019s Disease","volume":"39","author":"Kimura","year":"2024","journal-title":"Mov. Disord."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.peptides.2013.01.014","article-title":"Glucagon-like peptides 1 and 2 in health and disease: A review","volume":"44","author":"Marathe","year":"2013","journal-title":"Peptides"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The Microbiota-Gut-Brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","article-title":"Parkinson\u2019s disease and the gastrointestinal microbiome","volume":"267","author":"Lubomski","year":"2020","journal-title":"J. Neurol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Zha, X., Liu, X., Wei, M., Huang, H., Cao, J., Liu, S., Bian, X., Zhang, Y., Xiao, F., and Xie, Y. (2024). Microbiota-derived lysophosphatidylcholine alleviates Alzheimer\u2019s disease pathology via suppressing ferroptosis. Cell Metab.","DOI":"10.1016\/j.cmet.2024.10.006"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2004555","DOI":"10.1002\/advs.202004555","article-title":"Trojan Horse Delivery of 4,4\u2032-Dimethoxychalcone for Parkinsonian Neuroprotection","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/23\/13042\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:46:48Z","timestamp":1760114808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/23\/13042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":151,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["ijms252313042"],"URL":"https:\/\/doi.org\/10.3390\/ijms252313042","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]}}}